These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 20528220

  • 21. Antenatal treatment of a mother bearing a fetus with congenital adrenal hyperplasia.
    Brook CG.
    Arch Dis Child Fetal Neonatal Ed; 2000 May; 82(3):F176-81. PubMed ID: 10794782
    [No Abstract] [Full Text] [Related]

  • 22. Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint.
    Hirvikoski T, Nordenström A, Wedell A, Ritzén M, Lajic S.
    J Clin Endocrinol Metab; 2012 Jun; 97(6):1881-3. PubMed ID: 22466333
    [No Abstract] [Full Text] [Related]

  • 23. On cultural sanctions for shaping our children's genitalia.
    Lantos J.
    Am J Bioeth; 2010 Sep; 10(9):55-7. PubMed ID: 20818564
    [No Abstract] [Full Text] [Related]

  • 24. Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia.
    Pang S, Clark AT, Freeman LC, Dolan LM, Immken L, Mueller OT, Stiff D, Shulman DI.
    J Clin Endocrinol Metab; 1992 Jul; 75(1):249-53. PubMed ID: 1619017
    [Abstract] [Full Text] [Related]

  • 25. [Peculiarities of stress-reactivity of hypothalamo-pituitary-adrenal system in prenatally stressed rats exposed to dexamethasone].
    Nosenko ND.
    Fiziol Zh (1994); 2008 Jul; 54(3):22-7. PubMed ID: 18763576
    [Abstract] [Full Text] [Related]

  • 26. Preventing female virilisation in congenital adrenal hyperplasia: The controversial role of antenatal dexamethasone.
    Heland S, Hewitt JK, McGillivray G, Walker SP.
    Aust N Z J Obstet Gynaecol; 2016 Jun; 56(3):225-32. PubMed ID: 26661642
    [Abstract] [Full Text] [Related]

  • 27. Prenatal diagnosis and management of congenital adrenal hyperplasia.
    Speiser PW, New MI.
    Clin Perinatol; 1994 Sep; 21(3):631-45. PubMed ID: 7982338
    [Abstract] [Full Text] [Related]

  • 28. [Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 9 treated pregnancies].
    Nivelon JL, Chouchane M, Forest MG, Morel Y, Huet F, Nivelon-Chevallier A, François C.
    Ann Pediatr (Paris); 1993 Sep; 40(7):421-5. PubMed ID: 7902059
    [Abstract] [Full Text] [Related]

  • 29. Prenatal diagnosis and treatment of congenital adrenal hyperplasia.
    Levine LS, Pang S.
    J Pediatr Endocrinol; 1994 Sep; 7(3):193-200. PubMed ID: 7820212
    [Abstract] [Full Text] [Related]

  • 30. The pituitary-adrenal axis of fetal rats after maternal dexamethasone treatment.
    Stojanoski MM, Nestorović N, Negić N, Filipović B, Sosić-Jurjević B, Milosević V, Sekulić M.
    Anat Embryol (Berl); 2006 Jan; 211(1):61-9. PubMed ID: 16374610
    [Abstract] [Full Text] [Related]

  • 31. Prenatal treatment of congenital adrenal hyperplasia: report of a new case.
    Loeuille GA, David M, Forest MG.
    Eur J Pediatr; 1990 Jan; 149(4):237-40. PubMed ID: 2406146
    [Abstract] [Full Text] [Related]

  • 32. Prenatal therapy in congenital adrenal hyperplasia. Attempted prevention of abnormal external genital masculinization by pharmacologic suppression of the fetal adrenal gland in utero.
    Chrousos GP, Evans MI, Loriaux DL, McCluskey J, Fletcher JC, Schulman JD.
    Ann N Y Acad Sci; 1985 Jan; 458():156-64. PubMed ID: 3879119
    [No Abstract] [Full Text] [Related]

  • 33. Why history matters: fetal dex and intersex.
    Reis E, Kessler S.
    Am J Bioeth; 2010 Sep; 10(9):58-9. PubMed ID: 20818565
    [No Abstract] [Full Text] [Related]

  • 34. Comments about the need for prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Migeon CJ.
    J Clin Endocrinol Metab; 1990 Apr; 70(4):836-7. PubMed ID: 2318944
    [No Abstract] [Full Text] [Related]

  • 35. Endocrinologic and psychological effects of short-term dexamethasone in anorexia nervosa.
    Gordon CM, Emans SJ, DuRant RH, Mantzoros C, Grace E, Harper GP, Majzoub JA.
    Eat Weight Disord; 2000 Sep; 5(3):175-82. PubMed ID: 11082797
    [Abstract] [Full Text] [Related]

  • 36. New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002-2011).
    Tardy-Guidollet V, Menassa R, Costa JM, David M, Bouvattier-Morel C, Baumann C, Houang M, Lorenzini F, Philip N, Odent S, Guichet A, Morel Y.
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1180-8. PubMed ID: 24471566
    [Abstract] [Full Text] [Related]

  • 37. How safe is long-term prenatal glucocorticoid treatment?
    Seckl JR, Miller WL.
    JAMA; 1997 Apr 02; 277(13):1077-9. PubMed ID: 9091698
    [No Abstract] [Full Text] [Related]

  • 38. Congenital adrenal hyperplasia: do the benefits of prenatal treatment defeat the risks?
    Vos AA, Bruinse HW.
    Obstet Gynecol Surv; 2010 Mar 02; 65(3):196-205. PubMed ID: 20214835
    [Abstract] [Full Text] [Related]

  • 39. Sequential use of hydrocortisone and dexamethasone in prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Uçar A, Saka N, Baş F, Poyrazoğlu S, Bundak R, Darendeliler F.
    Horm Res Paediatr; 2013 Mar 02; 79(5):323-4. PubMed ID: 23711741
    [No Abstract] [Full Text] [Related]

  • 40. Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish children and adolescents at risk of congenital adrenal hyperplasia.
    Wallensteen L, Karlsson L, Messina V, Gezelius A, Sandberg MT, Nordenström A, Hirvikoski T, Lajic S.
    Horm Behav; 2018 Feb 02; 98():219-224. PubMed ID: 29410007
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.